SII - NewsroomPost

No recommendations for COVID-19 booster dose by SEC: Sources

No recommendations for COVID-19 booster dose by SEC: Sources

ANI

‘No antibodies despite taking Covishield dose’: UP man lodges complaint against SII CEO, ICMR chief Adar Poonawala

‘No antibodies despite taking Covishield dose’: UP man lodges complaint against SII CEO, ICMR chief Adar Poonawala

ANI

Unite in beating Coronavirus: Adar Poonawalla requests Joe Biden to lift embargo of raw material exports out of US to ramp up vaccine production

Unite in beating Coronavirus: Adar Poonawalla requests Joe Biden to lift embargo of raw material exports out of US to ramp up vaccine production

Newsroom Staff

Major fire at Serum Institute of India, 5 dead; Covishield vaccine manufacturing facility unaffected

Major fire at Serum Institute of India, 5 dead; Covishield vaccine manufacturing facility unaffected

Newsroom Staff

Will produce 70-80 million doses every month, plans underway to see requirement for India: SII CEO Poonawalla

Will produce 70-80 million doses every month, plans underway to see requirement for India: SII CEO Poonawalla

Newsroom Staff

SII CEO Poonawalla thanks PM Modi for his invaluable support after seeking emergency authorisation of its COVID vaccine

SII CEO Poonawalla thanks PM Modi for his invaluable support after seeking emergency authorisation of its COVID vaccine

Newsroom Staff

Serum Institute of India to apply for emergency use of vaccine in 2 weeks

Serum Institute of India to apply for emergency use of vaccine in 2 weeks

Newsroom Staff

3 COVID-19 vaccines at clinical trial stage in India, SII to begin Phase 3 trial soon: ICMR

3 COVID-19 vaccines at clinical trial stage in India, SII to begin Phase 3 trial soon: ICMR

Newsroom Staff

© 2024, All Rights Reserved by Headlong Newsroom Post India Private Limited